TOP STORIES

• REGULATORY Japan Approves Mounjaro, Tezspire, Fintepla, Label Expansions for Rinvoq/Skyrizi, Keytruda, and More
  September 27, 2022

• BUSINESS Ivermectin Misses Goal in PIII COVID-19 Trial: Kowa
  September 27, 2022

• REGULATORY Revamped Expert Panel Holds Industry Hearing, Discussions Center on Drug Price Gap
  September 26, 2022

• BUSINESS Janssen Aims to Rank Among Top 3 Drug Makers in Japan by 2024: Local Chief
  September 22, 2022

• REGULATORY 2 Years after Full Rollout, Sakigake System Shows Tepid Uptake as Industry Sees Poor Incentives
  September 21, 2022

• REGULATORY MHLW Retools New Expert Panel, Industry Hearing Set for Sept. 22
  September 21, 2022

• BUSINESS Boehringer Ingelheim Revamping Biz Sites in Japan to Spur Communications among Drug Reps
  September 20, 2022

• BUSINESS Insmed CEO Sees Japan as Cornerstone of APAC Strategy, Doubling of Staff in Next 2 Years
  September 16, 2022

• BUSINESS Moderna to Have One of Industry’s Biggest Pipelines in 5 Years, Oncology Might Make Up 30% of Sales: CEO
  September 15, 2022

• BUSINESS Alnylam Japan Paints Two-Digit Annual Growth Outlook on ATTR Meds and Pipeline Drugs
  September 14, 2022

• BUSINESS Pfizer Seeks Japan Nod for BA.4/5-Adapted COVID-19 Vaccine
  September 13, 2022

• REGULATORY Japan OKs Omicron COVID-19 Vaccines from Pfizer, Moderna
  September 13, 2022

• COMMENTARY Delving into Potential Implications of Envisaged Price Revision Overhaul
  September 12, 2022

• ORGANIZATION FPMAJ-Eyed Overhaul of Price Revision Rules Likely to Curb Price Falls, Cover JP-Listed Meds, Essential Drugs and More
  September 9, 2022

• BUSINESS Lagevrio’s Normal Distribution to Start from Sept. 16: MSD
  September 9, 2022

• ACADEMIA University of Tokyo to Open Pathogen Research Facility to Drug Makers, CROs to Accelerate Vaccine Development
  September 8, 2022

• REGULATORY Pfizer/Moderna’s Omicron Vaccines on Japan Panel Agenda on Sept. 12
  September 8, 2022

• ORGANIZATION Ex-MHLW Official Isobe, Now at Self-Medication Group, Touts OTC Use to Soften Impact of Off-Year Re-Pricing
  September 7, 2022

• BUSINESS Pfizer Japan to Stop Amoxapine Shipments, Start Recall in February after Carcinogen Detection
  September 7, 2022

• REGULATORY MHLW Study Group to Ponder Support Measures for Stable Generic Supplies
  September 6, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 65
• 66
• 67
• 68
• 69
• 70
• 71
• 72
• 73
• …
• Next ›
• 最終 »